Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT01503320
Eligibility Criteria:
Inclusion Criteria:
* Patients over the age 18.
* Patient admitted within 72hrs of onset of abdominal pain for over 24hr with raised (\>3- fold) serum lipase/amylase on admission.
* Marshall Score of ≥ 2 in any one organ, excluding the liver component
* Pancreatic necrosis \>30% on Computed tomography (CT) scan or a modified CT severity index of ≥6.
* Apache II score ≥8.
* BUN at admission of \>20mg/dL or an BUN elevation of \>5mg/dL within 48hrs of admission.
Exclusion Criteria:
* Patients with chronic pancreatitis and pancreatic insufficiency requiring pancreatic enzyme supplements.
* Pre-existing chronic renal insufficiency requiring hemodialysis or peritoneal dialysis.
* Patients with ARF.
* Pre-existing end-stage liver disease with ascites, coagulopathy and encephalopathy.
* Pancreatic cancer.
* Current somatostatin or corticosteroid therapy.
* Any form of artificial feeding since commencement of acute pancreatitis symptoms.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01503320
Study Brief:
Protocol Section:
NCT01503320